Comparison of treatment outcome of NHL-BFM-90/95 and CHOP/R-CHOP regimen for children and adolescents with diffuse large B cell lymphoma

被引：0
|
作者：
Sun, Fei-Fei [1 ,2 ]
Zhen, Zi-Jun [1 ,2 ]
Zhu, Jia [1 ,2 ]
Lu, Su-Ying [1 ,2 ]
Wang, Juan [1 ,2 ]
Li, Peng-Fei [1 ,2 ]
Liao, Ru [1 ,2 ]
Huang, Hui-Qiang [1 ,3 ,4 ]
Xia, Zhong-Jun [1 ,3 ,4 ]
Sun, Xiao-Fei [1 ,2 ]
机构：
[1] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Pediat Oncol, Taipei, Taiwan
[3] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
[4] State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2015年 / 171卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
118
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [21] Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
    Tomita, Naoto
    Takasaki, Hirotaka
    Fujisawa, Shin
    Miyashita, Kazuho
    Ogusa, Eriko
    Kishimoto, Kumiko
    Matsuura, Shiro
    Sakai, Rika
    Koharazawa, Hideyuki
    Yamamoto, Wataru
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Ishii, Yoshimi
    Taguchi, Jun
    Kuwabara, Hideyuki
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2013, 53 (02) : 121 - 125
  • [22] Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
    Tomita, Naoto
    Takasaki, Hirotaka
    Fujisawa, Shin
    Miyashita, Kazuho
    Ogusa, Eriko
    Kishimoto, Kumiko
    Matsuura, Shiro
    Sakai, Rika
    Koharazawa, Hideyuki
    Yamamoto, Wataru
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Yamamoto, Yoshimi
    Taguchi, Jun
    Kuwabara, Hideyuki
    Motomura, Shigeki
    Ishigatsubo, Yoshiaki
    BLOOD, 2011, 118 (21) : 708 - 709
  • [23] Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis
    Painschab, Matthew S.
    Kohler, Racquel
    Kimani, Stephen
    Mhango, Wilberforce
    Kaimila, Bongani
    Zuze, Takondwa
    Mithi, Victor
    Kasonkanji, Edwards
    Mumba, Noel
    Nyasosela, Richard
    Wheeler, Stephanie
    Gopal, Satish
    LANCET GLOBAL HEALTH, 2021, 9 (09): : E1305 - E1313
  • [24] Improving R-CHOP in diffuse large B-cell lymphoma is still a challenge
    Jardin, Fabrice
    LANCET ONCOLOGY, 2019, 20 (05): : 605 - 606
  • [25] Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma
    Miura, Katsuhiro
    Takahashi, Hiromichi
    Nakagawa, Masaru
    Hamada, Takashi
    Uchino, Yoshihito
    Iizuka, Kazuhide
    Ohtake, Shimon
    Iriyama, Noriyoshi
    Hatta, Yoshihiro
    Nakamura, Hideki
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (06) : 583 - 595
  • [26] Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma
    Gouni, Sushanth
    Strati, Paolo
    Toruner, Gokce
    Aradhya, Akanksha
    Landgraf, Ralf
    Bilbao, Daniel
    Vega, Francisco
    Agarwal, Nitin Kumar
    LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1302 - 1313
  • [27] The modified program NHL-BFM-90 in the treatment of patients with diffuse large B-cell lymphosarcoma
    Magomedova, A. U.
    Kravchenko, S. K.
    Kremenetskaya, A. M.
    Zvonkov, E. E.
    Baryakh, E. A.
    Margolin, O. V.
    Kaplanskaya, I. B.
    Vorobyev, I. A.
    Samoilova, R. S.
    Obukhova, T. N.
    Moiseeva, T. N.
    Zybunova, E. E.
    Genuligyan, E. G.
    Vorobyev, A. I.
    TERAPEVTICHESKII ARKHIV, 2006, 78 (10) : 44 - 47
  • [28] R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma
    Lee, Hong Ghi
    Choi, Yunsuk
    Kim, Sung-Yong
    Kim, Inho
    Kim, Yeo-Kyeoung
    Kim, Yang Soo
    Lee, Ho Sup
    Kim, Seok Jin
    Kim, Jeong-A
    Park, Byeong-Bae
    Park, Jinny
    Shim, Hyeok
    Eom, Hyeon Seok
    Lee, Junglim
    Park, Sung Kyu
    Cheong, June-Won
    Park, Keon Woo
    BLOOD RESEARCH, 2014, 49 (02) : 107 - 114
  • [29] Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
    Takeshi Hara
    Hisashi Tsurumi
    Naoe Goto
    Nobuhiro Kanemura
    Takeshi Yoshikawa
    Senji Kasahara
    Toshiki Yamada
    Michio Sawada
    Hideko Goto
    Kenji Fukuno
    Jun-ichi Kitagawa
    Ichiro Yasuda
    Naoki Katsumura
    Masao Takemura
    Takeshi Takahashi
    Tsuyoshi Takami
    Hisataka Moriwaki
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1421 - 1428
  • [30] Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
    Hara, Takeshi
    Tsurumi, Hisashi
    Goto, Naoe
    Kanemura, Nobuhiro
    Yoshikawa, Takeshi
    Kasahara, Senji
    Yamada, Toshiki
    Sawada, Michio
    Goto, Hideko
    Fukuno, Kenji
    Kitagawa, Jun-ichi
    Yasuda, Ichiro
    Katsumura, Naoki
    Takemura, Masao
    Takahashi, Takeshi
    Takami, Tsuyoshi
    Moriwaki, Hisataka
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1421 - 1428
12345